Does X-Men, Spiderman & Hulk like Superheroes exist in reality? Yes…

Author: Akanksha Aggarwal Homo Superiors are superior Homo sapiens or super humans. This superiority can be beautiful, interesting and magical. Most of us have seen super hero movies like X-Men, Spider man, Deadpool, Hulk where normal men undergoes mutation and turn into super heroes having special body abilities. So are those movies just fiction or …

Sareum gets US patent on Pyrazolopyridines to treat Cancer

Sareum, which is a specialist in cancer drug discovery, received a patent from US Patent and Trademark Office for compounds (Pyrazolopyridines) that can inhibit CHK1 kinase enzyme and thereby helping in cancer treatment. Sareum deals with the discovery of small drug molecules for cancer and autoimmune diseases. There are various types of drugs which …

Ranbaxy at back foot: Punjab’s plant (4th in India) banned by FDA

Ranbaxy Laboratories which is one of the largest and reputed companies of India, exports its drugs throughout the world. U.S. is the main consumer of generic drugs made at Ranbaxy but due to one defect found in the drugs of Toansa plant in Punjab, Ranbaxy got a setback on their reputation. This is the fourth plant of India which was banned by U.S. Food …

Patent on ICE COLD-PCR to Transgenomic, Inc.

Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases. It deals with patient testing, biomarker identification, and genetic assays through clinical trials on patients. Transgenomic Company recently got a patent of ICE COLD-PCR technology from U.S. Patent and Trademark Office, …

Efavirenz (HIV Drug) case: Bristol (BMS) won over Mylan Pharma

Bristol Meyers Squibb (BMS), manufacturers of Efavirenz (patented drug for HIV) won over the companies named Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd. that made generic version of Efavirenz that is Sustiva. The companies filed an application in court for the permission to manufacture and sell Sustiva before the patent granted for Efavirenz …

Pharmaceutical Companies shift from Small Molecule Drugs to Biotech Drugs

Recently, the Tufts University’s Center for the Study of Drug Development (CSDD) released an interesting report revealing the dramatic shift of pharmaceutical companies from manufacturing small molecule drugs to a large number of biotechnology drugs. The report shows that in 2001, the biotech products worldwide accounted for only 7% of the revenue …

ViaCyte: Regenerative Medicine and Cell Therapy Derived from Stem Cells

ViaCyte Inc. is emerging as a leader in regenerative medicine and is all set to develop a new approach for the treatment of major diseases using cell therapy derived from stem cells. The company was granted 28 patents in 2011-2013 of which 17 are US and remaining 11 in other countries. Among the 11 patents, one of the patents got granted in Europe patent …

‘Fire In the Blood’ – An Eye Opener for Patent Law Makers in Pharmaceuticals

Fire in the Blood, is a documentary on “medicine, monopoly and malice.” It tells the story of how Western pharmaceutical companies and governments blocked access to low-cost AIDS drugs for the countries of the global south in the years after 1996 – causing ten million or more unnecessary deaths – and the improbable group of people …